Previously, in a published systematic review involving studies until 25 April 2017, we identified few studies that provided quality information on effect of glycemic control and/or insulin (with or without oral hypoglycemic agents compared to oral hypoglycemic agents alone) on TB treatment outcomes among individuals with TB and DM (TB-DM) [20]. Here, INS is linked to tuberculosis.